National Research Co. (NASDAQ:NRC) Stock Position Lessened by Comerica Bank

Comerica Bank cut its stake in National Research Co. (NASDAQ:NRC) by 5.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 94,137 shares of the company’s stock after selling 5,651 shares during the period. Comerica Bank owned approximately 0.40% of National Research worth $1,661,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of NRC. Northern Trust Corp boosted its position in National Research by 2.7% during the 4th quarter. Northern Trust Corp now owns 293,755 shares of the company’s stock worth $5,182,000 after acquiring an additional 7,853 shares during the period. Price T Rowe Associates Inc. MD boosted its position in National Research by 5.6% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 14,250 shares of the company’s stock worth $252,000 after purchasing an additional 752 shares during the period. Tower Research Capital LLC TRC grew its stake in National Research by 376.6% in the 4th quarter. Tower Research Capital LLC TRC now owns 2,507 shares of the company’s stock valued at $44,000 after buying an additional 1,981 shares during the last quarter. MetLife Investment Management LLC grew its position in shares of National Research by 28.7% in the fourth quarter. MetLife Investment Management LLC now owns 11,630 shares of the company’s stock valued at $205,000 after purchasing an additional 2,592 shares during the last quarter. Finally, XTX Topco Ltd acquired a new stake in National Research in the 4th quarter valued at approximately $190,000. 47.26% of the stock is currently owned by institutional investors and hedge funds.

National Research Stock Down 3.8 %

NRC stock opened at $12.91 on Friday. The company has a market cap of $296.23 million, a PE ratio of 12.30 and a beta of 0.34. The company has a quick ratio of 0.47, a current ratio of 0.47 and a debt-to-equity ratio of 1.30. National Research Co. has a twelve month low of $9.76 and a twelve month high of $32.48. The business’s 50-day simple moving average is $12.76 and its 200 day simple moving average is $16.07.

National Research (NASDAQ:NRC) last released its quarterly earnings data on Monday, April 28th. The company reported $0.25 earnings per share (EPS) for the quarter. National Research had a return on equity of 66.52% and a net margin of 17.32%. The firm had revenue of $33.55 million during the quarter.

National Research Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 11th. Shareholders of record on Friday, June 27th will be paid a $0.12 dividend. The ex-dividend date is Friday, June 27th. This represents a $0.48 dividend on an annualized basis and a yield of 3.72%. National Research’s payout ratio is presently 46.60%.

National Research Company Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.